The First GR Kitchen & Taps Coming to Downtown Waterloo, IA restaurantnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from restaurantnews.com Daily Mail and Mail on Sunday newspapers.
B2B Insurtech Platform Boost Raises $20M Series B to Make Insurance Market Accessible for All Companies
Infrastructure-as-a-Service Leader Unlocks a $700 Billion P&C Insurance Market Opportunity for Companies Across Industries
News provided by
Share this article
NEW YORK, May 20, 2021 /PRNewswire/
Boost Insurance ( Boost ), the leading B2B digital insurance platform, today announced that it has completed a $20 million Series B financing round to fuel growth of its platform, new product development and partner marketing. The round was led by RRE Ventures and included new investors Fin VC, Gaingels, Hack VC and a global publicly traded reinsurance company along with existing investors Greycroft, Coatue, and Conversion Capital. Boost s funding since inception totals $37 million.
New Report By European Women In VC Spotlights CEE Venture Capital Funding Through The Gender Lens forbes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forbes.com Daily Mail and Mail on Sunday newspapers.
Paravision, a U.S.-based leader in mission-critical face recognition and computer vision, today announced that it has raised $23 million in its latest funding round led by J2 Ventures, with participation from HID Global, Marlinspike Capital, Atomic, Icon Ventures, Perot Jain, Red Cell Partners, and other investors.
This round of investment reflects Paravision’s emergence as the technology partner of choice in a rapidly expanding space. Driven by the need for fast, accurate, touchless, and frictionless identity, the global market for face recognition is accelerating across a wide range of applications including enterprise security, consumer identity verification, government services, travel, and payments.
Share this article
Share this article
TEL AVIV, Israel, May 5, 2021 /PRNewswire/ The U.S. Food and Drug Administration (FDA) has granted Donisi s revolutionary contact-free multiparameter measurement system de novo clearance, making Donisi the first to bring this innovative technology to the medical market.
In addition to the de novo clearance, the ingenuity of Donisi s groundbreaking system was recently recognized via the publication of their clinical validation study in the Journal of Medical Engineering & Technology and winning first place in the MEDinISRAEL OpenMED Innovation Competition.
Contact-Free Health Measurement and Decision Support. Donisi: Changing Lives Without Changing Lifestyles I m really proud of our team; we developed a medical device that can change the lives of millions of people. Our novel technology is now recognized and cleared by FDA which is a great accomplishment, said Donisi CEO, Yair Brosh.